INTRAUMA
Generated 5/10/2026
Executive Summary
INTRAUMA is a privately held Italian medical device company headquartered in Verona, founded in 2007. The company specializes in developing, manufacturing, and marketing orthopedic implants and sterile kits for trauma and spine surgery, with a particular focus on extremities such as the tibia, femur, and ankle. Its product portfolio targets both human orthopedics and a dedicated veterinary division (VET). INTRAUMA also maintains an active international export business, suggesting a geographically diversified revenue base. Despite being private with limited public financial disclosures, the company's longevity and niche focus in extremity trauma and spine implants position it as a specialized player in the orthopedic device market.
Upcoming Catalysts (preview)
- Q3 2026Launch of next-generation extremity implant system55% success
- Q1 2027FDA 510(k) clearance for a trauma implant40% success
- Q2 2026Partnership or distribution agreement for veterinary product line expansion60% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)